Filing Details
- Accession Number:
- 0001415889-24-014103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-22 16:36:56
- Reporting Period:
- 2024-05-20
- Accepted Time:
- 2024-05-22 16:36:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1923840 | Third Harmonic Bio Inc. | THRD | Pharmaceutical Preparations (2834) | 834553503 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2022925 | Jennifer Dittman | C/O Third Harmonic Bio, Inc. 1700 Montgomery Street, Suite 210 San Francisco CA 94111 | Chief Development Oper Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-20 | 1,042 | $4.30 | 1,042 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-05-20 | 1,042 | $14.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-05-20 | 1,042 | $0.00 | 1,042 | $4.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,292 | 2032-12-18 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule I 0b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
- 25% of the total shares vest on December 19, 2023, and thereafter 2.08333% of the total shares uoderlying the award shall vest in equal monthly installmeots uotil fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date
Billionaire Hedge Funds
